Scarica l'app Stockscreener
37.99
0.18%
0.07
Dopo l'orario di chiusura:
37.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$37.92
Aprire:
$37.65
Volume 24 ore:
229.88K
Relative Volume:
1.85
Capitalizzazione di mercato:
$543.23M
Reddito:
$138.20M
Utile/perdita netta:
$5.52M
Rapporto P/E:
99.97
EPS:
0.38
Flusso di cassa netto:
$9.86M
1 W Prestazione:
+8.45%
1M Prestazione:
+23.06%
6M Prestazione:
+11.21%
1 anno Prestazione:
-5.07%
Intervallo 1D:
$37.65
$38.31
Intervallo di 1 settimana:
$34.76
$38.50
Portata 52W:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Nome
Surmodics Inc
Settore
Industria
Telefono
(952) 500-7000
Indirizzo
9924 W 74TH ST, EDEN PRAIRIE, MN
Confronta SRDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
37.99 | 543.31M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-07 | Aggiornamento | Lake Street | Hold → Buy |
| 2023-06-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-02-13 | Downgrade | Needham | Buy → Hold |
| 2020-07-23 | Aggiornamento | Needham | Hold → Buy |
| 2019-12-11 | Downgrade | Needham | Buy → Hold |
| 2019-11-01 | Downgrade | Lake Street | Buy → Hold |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Lake Street | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-02-21 | Reiterato | Needham | Buy |
| 2018-05-16 | Reiterato | Needham | Buy |
| 2018-03-01 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-02-28 | Reiterato | Lake Street | Buy |
| 2018-02-28 | Iniziato | Needham | Buy |
| 2017-07-14 | Iniziato | Lake Street | Buy |
| 2016-11-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-10-06 | Downgrade | Sidoti | Buy → Neutral |
| 2016-05-03 | Reiterato | Barrington Research | Outperform |
| 2015-08-06 | Reiterato | Barrington Research | Outperform |
| 2015-03-27 | Iniziato | Dougherty & Company | Buy |
| 2014-02-25 | Iniziato | Laidlaw | Buy |
| 2013-08-01 | Aggiornamento | Feltl & Co. | Buy → Strong Buy |
| 2012-11-12 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Surmodics Inc Borsa (SRDX) Ultime notizie
FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix - Law360
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts - TradingView
What is the target price for Surmodics Inc. stockPrice Volume Breakout Screener - newsyoung.net
Is Surmodics Inc. exposed to political riskQuality Dividend Stock Finder - newsyoung.net
Surmodics (SRDX) Maintains Market Perform Rating by Barrington Research - AInvest
SurModics Maintains Hold Rating Amid Mixed Financial Performance and Ongoing Litigation - AInvest
Surmodics revenue down 3% to USD 29.6M in Q3 2025 - Medical Buyer
Surmodics 2025 Q3 Earnings Loss Narrows 29.6% - AInvest
SurModics' Strong Financials Offset by Acquisition Uncertainty - AInvest
SurModics: Fiscal Q3 Earnings Snapshot - Connecticut Post
Surmodics Lifts Guidance Despite Dips In Device Revenue - Finimize
GTCR, Surmodics file opposition to US FTC's motion for preliminary injunction - MLex
UPDATE: FTC request for GTCR/Surmodics divestiture docs denied - Global Competition Review
FTC seeks GTCR/Surmodics divestiture docs - Global Competition Review
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
SurModics earnings beat by $0.25, revenue topped estimates - Investing.com Canada
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
SURMODICS INC SEC 10-Q Report - TradingView
Surmodics raises FY25 EPS view to (35c)-(20c) from (62c)-(42c) - TipRanks
SURMODICS Earnings Results: $SRDX Reports Quarterly Earnings - Quiver Quantitative
Medical device maker Surmodics's Q3 revenue dips 3%, FY guidance raised - MarketScreener
Surmodics (SRDX) Q3 EPS Turns Positive - AOL.com
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - The Globe and Mail
Surmodics Reports Third Quarter Fiscal 2025 Financial Results - TradingView
What data driven models say about Surmodics Inc.’s futureDaily Trade Monitor with Pattern Alerts - Newser
Will Surmodics Inc. rebound enough to break evenRSI and MACD Signal Summary with Trends - Newser
Is Surmodics Inc. meeting your algorithmic filter criteriaAsset Growth Pattern and Return Summary - Newser
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - BioSpace
Press Release: Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - 富途牛牛
Is it the right time to buy Surmodics Inc. stockUnmatched profit growth - Jammu Links News
How does Surmodics Inc. generate profit in a changing economyAchieve breakthrough performance in the market - Jammu Links News
Why is Surmodics Inc. stock attracting strong analyst attentionUnlock superior stock analysis tools - Jammu Links News
When is Surmodics Inc. stock expected to show significant growthDiscover the fastest growing stocks today - Jammu Links News
How many analysts rate Surmodics Inc. as a “Buy”Massive stock growth - Jammu Links News
Surmodics Inc. Stock Analysis and ForecastFree Capital Allocation Plans - Jammu Links News
What is the risk reward ratio of investing in Surmodics Inc. stockOutstanding investment returns - Jammu Links News
Analyzing drawdowns of Surmodics Inc. with statistical toolsFree Day Trading Signals With High Precision - Newser
how surmodics inc. stock performs during market volatilityCapital Growth Plan for New Investors - Newser
Is Surmodics Inc. stock a growth or value playFree Step-by-Step Trade Signal Implementation - Newser
Is this a good reentry point in Surmodics Inc.Free Daily Growth Stock Pick Reports - Newser
What institutional investors are buying Surmodics Inc. stockExpert Picks Planner For Beginners - Jammu Links News
Volume Surge May Signal Institutional Interest in Surmodics Inc.Real Trader Watchlist of Hot Stocks Released - metal.it
Is a relief rally coming for Surmodics Inc. holdersReal-Time Trade Insights Spark Market Reactions - metal.it
Surmodics falls as parties, FTC ask for extension of briefing schedule - Seeking Alpha
How Efficient Is Surmodics Inc. at Controlling Operating CostsBuy Strategy Tracker with Growth Indicators - Newser
Is Surmodics Inc. stock a good hedge against inflationControlled Entry Strategy With Safety Analytics - Newser
Surmodics Inc Azioni (SRDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surmodics Inc Azioni (SRDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):